IS8294A - Klópidógrel bísúlfat lyfjasamsetningar - Google Patents

Klópidógrel bísúlfat lyfjasamsetningar

Info

Publication number
IS8294A
IS8294A IS8294A IS8294A IS8294A IS 8294 A IS8294 A IS 8294A IS 8294 A IS8294 A IS 8294A IS 8294 A IS8294 A IS 8294A IS 8294 A IS8294 A IS 8294A
Authority
IS
Iceland
Prior art keywords
pharmaceutical compositions
clopidogrel bisulfate
clopidogrel
bisulfate
pharmaceutical
Prior art date
Application number
IS8294A
Other languages
English (en)
Other versions
IS2385B (is
Inventor
Torfi Emil Kristjansson
Original Assignee
Actavis Group Hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Hf filed Critical Actavis Group Hf
Priority to IS8294A priority Critical patent/IS2385B/is
Priority to AU2007213355A priority patent/AU2007213355A1/en
Priority to US12/223,693 priority patent/US20090060996A1/en
Priority to RU2008135718/15A priority patent/RU2008135718A/ru
Priority to EP07706202A priority patent/EP1991206A1/en
Priority to PCT/IS2007/000006 priority patent/WO2007091279A1/en
Publication of IS8294A publication Critical patent/IS8294A/is
Publication of IS2385B publication Critical patent/IS2385B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS8294A 2006-02-10 2006-02-10 Klópidógrel bísúlfat lyfjasamsetningar IS2385B (is)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IS8294A IS2385B (is) 2006-02-10 2006-02-10 Klópidógrel bísúlfat lyfjasamsetningar
AU2007213355A AU2007213355A1 (en) 2006-02-10 2007-02-09 Formulations of clopidogrel bisulphate
US12/223,693 US20090060996A1 (en) 2006-02-10 2007-02-09 Formulations of Clopidogrel Bisulphate
RU2008135718/15A RU2008135718A (ru) 2006-02-10 2007-02-09 Композиции клопидогреля бисульфата
EP07706202A EP1991206A1 (en) 2006-02-10 2007-02-09 Formulations of clopidogrel bisulphate
PCT/IS2007/000006 WO2007091279A1 (en) 2006-02-10 2007-02-09 Formulations of clopidogrel bisulphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS8294A IS2385B (is) 2006-02-10 2006-02-10 Klópidógrel bísúlfat lyfjasamsetningar

Publications (2)

Publication Number Publication Date
IS8294A true IS8294A (is) 2007-08-11
IS2385B IS2385B (is) 2008-07-15

Family

ID=38050994

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8294A IS2385B (is) 2006-02-10 2006-02-10 Klópidógrel bísúlfat lyfjasamsetningar

Country Status (6)

Country Link
US (1) US20090060996A1 (is)
EP (1) EP1991206A1 (is)
AU (1) AU2007213355A1 (is)
IS (1) IS2385B (is)
RU (1) RU2008135718A (is)
WO (1) WO2007091279A1 (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1847258E (pt) † 2006-04-13 2010-06-22 Riemser Specialty Production G Glicéridos parciais como lubrificante para composições farmacêuticas que contêm derivados de tieno[3,2-c]piridina
EP2148655B1 (en) * 2007-04-20 2013-02-27 Wockhardt Limited Pharmaceutical compositions of clopidogrel
CN101427992B (zh) * 2007-11-07 2011-02-09 浙江华海药业股份有限公司 氯吡格雷氢溴酸盐制剂及其制备方法
ATE530172T1 (de) 2008-02-26 2011-11-15 Lesvi Laboratorios Sl Pharmazeutische formulierungen mit clopidogrel
CN101766573B (zh) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 硫酸氢氯吡格雷固体制剂的制备工艺
US20140179712A1 (en) * 2012-12-21 2014-06-26 Astrazeneca Ab Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
GB201400117D0 (en) * 2014-01-03 2014-02-19 Cycle Pharmaceuticals Ltd Pharmaceutical composition
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN112999180B (zh) * 2019-12-20 2022-08-30 青岛黄海制药有限责任公司 一种硫酸氢氯吡格雷晶型ⅱ片剂及其制备方法
CN114209675B (zh) * 2022-01-20 2023-06-02 北京微智瑞医药科技有限公司 一种硫酸氢氯吡格雷阿司匹林微片胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221390B1 (en) * 1997-08-25 2001-04-24 Barr Laboratories, Inc. Combination pharmaceutical composition and associated methods
US6492427B2 (en) * 1998-10-09 2002-12-10 L. Sai Latha Shankar Methods for treating multiple sclerosis
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
US20050096365A1 (en) * 2003-11-03 2005-05-05 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
GB0325603D0 (en) * 2003-11-03 2003-12-10 Sandoz Ag Organic compounds
WO2005070464A2 (en) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
EP1732932B1 (en) * 2004-04-09 2012-03-21 Hanmi Holdings Co., Ltd. Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same

Also Published As

Publication number Publication date
EP1991206A1 (en) 2008-11-19
IS2385B (is) 2008-07-15
US20090060996A1 (en) 2009-03-05
WO2007091279A1 (en) 2007-08-16
AU2007213355A1 (en) 2007-08-16
RU2008135718A (ru) 2010-03-20

Similar Documents

Publication Publication Date Title
DK2041139T3 (da) Farmaceutiske forbindelser
BRPI0715712A2 (pt) Composição farmacêutica
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
DK1986650T3 (da) Manipulationssikre doserignsformer
BRPI0719393A2 (pt) Composição farmacêutica
ATE512135T1 (de) Spiroindolinonderivate
RU2493831C3 (ru) Фармацевтические композиции
DK2081937T3 (da) Triazolopyridazin-proteinkinasemodulatorer
DK2228086T3 (da) Forstøver
DK2035394T3 (da) 2-pyrazincarboxamidderivater
DE602007001280D1 (de) Getränkeextraktor
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
IS2385B (is) Klópidógrel bísúlfat lyfjasamsetningar
ATE544764T1 (de) 5-hydroxymethyloxazolidin-2-onderivate
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0820198A2 (pt) composições farmacêuticas
DE602007010950D1 (de) Dosierpumpe
DE112007003147A5 (de) Rohr-Biegevorrichtung
ES1064046Y (es) Multiventuri dosificador
DE602007011978D1 (de) Stoffnuancierleitfaden
ATE473994T1 (de) Avermectinderivate
ITMI20061734A1 (it) Composizione farmaceutica